A股異動 | 日辰股份(603755.SH)跌逾5% 終止實施2021年股票期權激勵計劃
格隆匯6月10日丨日辰股份(603755.SH)跌逾5%,報63.17元,成交額放大至8889萬元,總市值62.4億元。日辰股份9日晚公吿,公司董事會、監事會審議並通過了《關於終止實施2021年股票期權激勵計劃>的議案》。公司本次2021年股票期權激勵計劃所涉及的股票期權尚未授出,激勵對象未實際獲得股票期權,因此本次終止事項不產生相關股份支付費用。此前推出股票期權激勵計劃曾獲多家券商唱好。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.